CDX2 and acute myeloid leukemia: LysM:Cdx2 mice had significant neutrophil hypersegmentation compared with LysM-Cre controls (Fig. 4f, g), with leukocytosis, anemia, and splenomegaly (Fig. 4h–j), but unlike Scl:Cdx2 mice, did not exhibit thrombocytopenia (Supplementary Fig. 4a) and did not develop secondary AML.